Length of hospital and intensive care unit stay in patients with invasive candidiasis and/or candidemia treated with rezafungin: a pooled analysis of two randomised controlled trials
Authors
Patrick M. Honoré (ORCID: https://orcid.org/0000-0002-6697-4890)
Length of hospital and intensive care unit stay in patients with invasive candidiasis and/or candidemia treated with rezafungin: a pooled analysis of two randomised controlled trials
Patrick M. Honoré, Jesús Fortün, Marin H. Kollef, I Bielicka et al.
Citations
10 citations
Journal
Critical Care
Topics
Antifungal resistance and susceptibility
Field-Weighted Citation Impact (FWCI)
3.89
article
Length of hospital and intensive care unit stay in patients with invasive candidiasis and/or candidemia treated with rezafungin: a pooled analysis of two randomised controlled trials
Patrick M. Honoré, Jesús Fortün, Marin H. Kollef, I Bielicka, Matteo Bassetti, Sara Dickerson, Nick Manamley, Oliver A. Cornely, Hervé Dupont, José A. Vázquez, George R. Thompson, Peter G. Pappas, John Pullman, Taylor Sandison
article en
10 citations
Abstract
No abstract available for this paper.
Publication Tag
Critical CareVol. 28(1)
Institutions
University of Cologne (DE), Washington University in St. Louis (US), Instituto Cajal (ES), Augusta University (US), University of Alabama at Birmingham (US), CHU Dinant Godinne UCL Namur (BE), Centre Hospitalier Universitaire Amiens-Picardie (FR), Centre Hospitalier Universitaire Brugmann (BE), Centro San Giovanni di Dio Fatebenefratelli (IT), Centro de Investigación Biomédica en Red (ES), German Center for Infection Research (DE), Mundipharma (United Kingdom) (GB), Instituto Ramón y Cajal de Investigación Sanitaria (ES), Cidara Therapeutics (United States) (US), Ospedale Policlinico San Martino (IT), University Hospital Cologne (DE), University of California Davis Medical Center (US), Simplification des soins chez les patients complexes (FR), Université de Picardie Jules Verne (FR), University of Genoa (IT), University of California, Davis (US)